KLOSTERNEUBURG, Austria & ROCKVILLE, Md.--(BUSINESS WIRE)--VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics ...
Treatment-related toxicities of antibody-drug conjugates in breast cancer: A Bayesian network meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
Researchers from MD Anderson Cancer Center recently presented the discovery and preclinical evaluation of LLO-CD47, a novel protein-antibody conjugate linking anti-CD47 to Listeriolysin O (LLO), a ...
Scientists have installed mutations into the antibody fragment crystallizable region to aid antibody-drug conjugate ...
CD39 expression as a predictive biomarker for neoadjuvant treatment in muscle-invasive bladder cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...
Researchers from Elpiscience Biopharmaceuticals Inc. discussed the discovery and preclinical characterization of a novel NKG2A antibody-IL-2 mutant fusion protein – ES-015.129 – being developed as ...
Iron oxide-incorporated conjugated polymer nanoparticles, also known as conjugated polymer nanoparticles (CPNs), are highly fluorescent particles composed of a semiconductor light-emitting polymer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results